0001447348-16-000060.txt : 20160422
0001447348-16-000060.hdr.sgml : 20160422
20160422170942
ACCESSION NUMBER: 0001447348-16-000060
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20101201
FILED AS OF DATE: 20160422
DATE AS OF CHANGE: 20160422
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000835887
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133379479
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9147892800
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MADDON PAUL J
CENTRAL INDEX KEY: 0001250313
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23143
FILM NUMBER: 161587246
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4/A
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4/A
2010-12-01
2010-12-01
0
0000835887
PROGENICS PHARMACEUTICALS INC
PGNX
0001250313
MADDON PAUL J
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2010-12-01
4
P
0
5000
4.9
A
909891
D
Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
This transaction was executed in multiple trades at prices ranging from $4.85 to $4.98. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This report amends the report filed on December 1, 2010 in order to correct an administrative error in the issuer's records as to the number of shares beneficially owned by the reporting person reported in Column 5 of Table I.
/s/ Paul J. Maddon
2016-04-22